Physician profile
Robert B Smith
NPI 1932418019
$619.62
in general payments reported to CMS, 2019-2025
11 companies · $62.65 in 2025
The $62.65 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.77 · 2023: $112 · 2024: $365 · 2025: $62.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $231.86 | 2024 | |
| Alcon Vision LLC | $71.14 | 2023-2024 | Clareon |
| Novartis Pharmaceuticals Corporation | $57.86 | 2023 | |
| Sight Sciences, INC. | $55.53 | 2024 | Omni Surgical System |
| Topcon Healthcare, INC. | $43.53 | 2025 | |
| Bausch & Lomb Americas INC. | $38.62 | 2024-2025 | Retisert, Visudyne, Xipere |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.64 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $28.29 | 2019 | |
| Sun Pharmaceutical Industries INC. | $23.14 | 2023 | Cequa |
| Mallinckrodt Hospital Products INC. | $18.17 | 2023 | Acthar |
| Coopervision INC. | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.